A trial involving a blood test that can detect more than 50 different cancers has shown promising results among thousands of NHS patients in the UK, scientists have announced.

The Galleri test, currently available in the US, is also able to pinpoint from where in the body the disease is coming, with 85% accuracy, reports The Independent.

In the Symplify trial, the test detected cancer in 323 out of the 6 238 people who had visited their GP with suspected symptoms in England or Wales. Of the 323, 244 were subsequently diagnosed with cancer, giving a positive predictive accuracy of 75%, the researchers said.

Around 2% of patients with a negative result were found to have cancer, and overall, the test correctly revealed cancer 66% of the time…..more